MIA researchers feature on prestigious Highly Cited Researchers 2020 List

18 November 2020
Melanoma Institute Australia is proud to announce that MIA’s Co-Medical Directors, Professor Georgina Long AO and Professor Richard Scolyer, as well as MIA Faculty member Associate Professor Alex Menzies and former Faculty member Professor Rick Kefford AM, have been named on the annual Highly Cited Researchers™ 2020 list from Clarivate.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe. It identifies researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade.
Their names are drawn from the publications that rank in the top 1% by citations for field and publication year in the Web of Science™ citation index.
According to Clarivate, 6,167 researchers from more than 60 countries and regions have been recognized this year, with Australian research institutes continuing to punch above their weight. In a country of just 25 million, the number of Australian researchers recognized in 2020 is 305.
MIA Co-Medical Director Professor Georgina Long AO, whose video interview with Clarivate is featured online, said:
“This accolade is recognition of the ground-breaking work being carried out by the entire team at Melanoma Institute Australia as we continue our quest to develop treatments that will ultimately save the lives of all melanoma patients.”
Fellow Co-Medical Director of MIA Professor Richard Scolyer said:
“It is an honour to again be included on this list alongside several other MIA researchers and clinicians. It shows the phenomenal and ongoing impact that MIA’s work and research is having around the world.”
David Pendlebury, Senior Citation Analyst at the Institute for Scientific Information at Clarivate said:
“In the race for knowledge, it is human capital that is fundamental and this list identifies and celebrates exceptional individual researchers from Melanoma Institute Australia who are having a great impact on the research community as measured by the rate at which their work is being cited by others.”
Melanoma Institute Australia is affiliated with The University of Sydney
#HighlyCited2020

Australian researchers stopping melanoma in its tracks
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.

Virus-antibody combo shows promise for treating advanced melanoma
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.

It's time to outlaw sunburn on reality TV shows - enough is enough
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.

Identifying markers for optimal response
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?

Global Melanoma Research Report - July
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.

A day in the life of... Sarah Lane
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.

Differentiating moles from melanoma
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.

Introducing SunSense Sunscreen
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.

60 Minutes' MIA Patient Feature Program
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.

Training our future melanoma experts
Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.

Update from ASCO 2017
Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.

Diagnosing melanoma of the mouth
MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.

New practice-changing research will reduce the need for major surgery in many melanoma patients
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.

MIA researchers to share new findings at world's largest cancer conference
Researchers from MIA will present their latest research findings to the world’s largest oncology conference in early June.

Australian researchers pioneer life-extending treatment for advanced melanoma patients with brain tumours
Australian researchers are the first to demonstrate that patients with advanced melanoma which has spread to the brain can have increased life expectancy and possibly even beat the disease.

Melanoma March 2017 wraps up!
Melanoma March 2017 - that's a wrap! Thank you to everyone that helped make it happen.

Melanoma March 2017 helping kick start the Big Data for Melanoma national Research Project!
Thank you so much to all those who contributed in a variety of ways to Melanoma March 2017 in 17 different locations and more around the country! You have contributed to getting the Big Data for Melanoma national Research Project happening!

Whole genome sequencing finds unexpected genomic landscape in melanoma
By looking at the ‘dark matter’ of the genome, new research has found that genetic changes in acral and mucosal melanoma are completely different to mutations found in skin melanoma.

Shining a light on melanomas that aren't caused by the sun
‘Slip, slop, slap’ is synonymous with being Australian and playing it safe in the sun. These sun smart rules reduce our chances of getting melanoma of the skin. However, new research tells a different story for those affected by rarer forms of melanoma.